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Abstract 
Purpose: To investigate the possible protective role of curcumin and α-tocopherol against cisplatin-
induced nephrotoxicity in rat.  
Methods: Male Wistar rats were divided into five groups. Groups 1 and 2 were intraperitoneally (i.p.) 
injected with normal saline and cisplatin (20 mg/kg), respectively. Groups 3, 4 and 5 were pre-treated 
with a single doses of α-tocopherol (250 mg/kg), curcumin (200 mg/kg) and α-tocopherol with curcumin, 
respectively, for 24 h prior to the administration of cisplatin. After 72 h following injection, specimens 
were collected. Serum blood urea nitrogen (BUN), creatinine and malondialdehyde (MDA) levels, 
superoxide dismutase (SOD) and catalase activities, kidney histopathological study and gene 
expressions of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and p38 mitogen-
activated protein kinase (p38-MAPK) were investigated. 
Results: Pre-treatment with combined curcumin and α-tocopherol exhibited significantly reduced MDA 
levels and enhanced activities of SOD and catalase compared with cisplatin-treated group (p < 0.05). It 
also improved BUN as well as creatinine levels and kidney histopathology. Moreover, gene expressions 
of NADPH oxidase were decreased, whereas p38-MAPK gene expressions were not significant 
compared with cisplatin-treated group.  
Conclusion: Combined curcumin and α-tocopherol are able to reduce cisplatin-induced nephrotoxicity 
via possible inhibition of NADPH oxidase, resulting in improvement of kidney function and histology. 
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Cisplatin or cis-diamminedichloroplatinum (II) is 
the chemotherapeutic agent useful in the 
treatment of various cancers such as ovarian 
cancer and testicular cancer [1]. Unfortunately, it 
exerts various side effects in several organs 
particularly in the kidney [2]. Only days after 
initiating treatment, approximately one-third of 
cisplatin-treated patients exhibit reduced 
glomerular filtration rate and increased blood 
urea nitrogen (BUN) and creatinine levels [3]. 
The underlying mechanism of nephrotoxicity 
remains incompletely understood. Oxidative 
stress has been implicated in the pathogenesis 
of kidney injury induced by cisplatin through 
increasing reactive oxygen species (ROS) 
resulting in augmented oxidation reaction of 
macromolecules especially lipid, protein and 
nucleic acid and reducing activity of enzymatic 
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antioxidants such as SOD, glutathione 
peroxidase (GPX) and catalase [1,4]. ROS 
particularly superoxide radical (O2•-) and hydroxyl 
radical (•OH) play the important role in cisplatin-
induced acute renal failure by reducing renal 
blood flow and inducing tubular damage 
associated with increased renal contents of 
MDA, a biomarker of lipid peroxidation (LPO) [5]. 
NADPH oxidase is an enzyme which catalyzes 
the generation of O2•- in large amounts. O2•- is 
able to rapidly change into other ROS such as 
hydrogen peroxide (H2O2) and •OH [6]. 
Moreover, apoptosis also plays key role in 
cisplatin-induced renal cell injury [7]. Activated 
p38-MAPK has been implicated as a pro-
apoptotic cellular signaling during oxidative 
stress [8].  
 
Previous study provides evidence which 
supports that antioxidant supplementation is the 
important therapeutic strategy to abrogate kidney 
damage activated by cisplatin [9]. Curcumin, an 
active phenolic compound derived from the 
rhizomes of Curcuma longa used as a spice and 
food coloring shows various antioxidant abilities 
in vivo [10]. Treatment with curcumin has been 
reported to attenuate kidney dysfunction, 
histopathological alteration, oxidative stress and 
the reduced activities of enzymatic antioxidants 
induced by chemical agents [11]. The activity of 
curcumin alone is lower than that of the two-
compound mixture [12].  
 
Vitamin E is a fat-soluble antioxidant and 
includes tocopherols and tocotrienols. Αlpha-
tocopherol is the most biologically active form of 
vitamin E. Curcumin and/or vitamin E have been 
reported to exhibit effective antioxidant activity 
against L-thyroxine-induced rat testicular and 
hepatic oxidative stress [13]. The present study, 
therefore, aims to investigate the protective role 
of curcumin and α-tocopherol against cisplatin-






cis-Diamminedichloroplatinum (II), curcumin from 
Curcuma longa, α-tocopherol,  Bradford assay 
kits  and 10 % neutral buffered formalin solution 
were purchased from Sigma-Aldrich Chemical 
Company (USA). Thiobarbituric acid reactive 
substances (TBARS), SOD and catalase assay 
kits were obtained from Cell Biolabs, Inc (USA).  
RNeasy mini kit, Omniscript RT kit and HotStar 
Taq DNA polymerase were purchased from 




Twenty-five male Wistar rats (Rattus 
norvegicus), ranging from 180-200 g body weight 
(BW), were obtained from Division of Animal 
House, Faculty of Science, Prince of Songkla 
University, Thailand. All animal procedures were 
reviewed and approved by Animal Ethics 
Committee, Walailak University (Protocol no. 
004/2012) and were conducted according to the 
Guide for the Care and Use  of Laboratory 
Animals, National Research Council [14]. The 
rats were maintained in stainless-steel cages 
under constant conditions of temperature (23 ± 2 
ºC), relative humidity (50 – 60 %) and lighting (12 
h light/dark cycles). They were provided with 
standard commercial rat feed (Division of Animal 
House, Faculty of Science, Prince of Songkla 
University, Thailand) and distilled water, and 
were acclimatized and closely monitored under 
laboratory conditions for 2 weeks prior to 
experimentation. 
 
Experimental design and specimen collection 
 
The rats were divided in five groups. Group 1 
was treated with a single i.p. injection of normal 
saline. Group 2 was injected with a single dose 
of cisplatin (20 mg/kg, i.p.). Groups 3, 4 and 5 
were treated with a single doses of α-tocopherol 
(250 mg/kg BW) alone, curcumin (200 mg/kg 
BW) alone and α-tocopherol (250 mg/kg BW) 
plus curcumin (200 mg/kg BW), respectively, via 
i.p. route, 24 h prior to a single-dose injection of 
cisplatin (20 mg/kg BW). Seventy two hours (72 
h) after the first injection, the rats were 
anesthetized with thiopental sodium 
intraperitoneally (50 mg/kg BW). Peripheral 
blood from heart was collected in clotted tubes 
and the rats euthanized by anesthetizing with an 
overdose of thiopental sodium (100 mg/kg BW). 
The abdominal cavity of rats was opened, the 
kidneys immediately collected and then washed 
in ice-cold isotonic saline.  
 
Determination of serum BUN and creatinine 
levels 
 
The peripheral heart blood samples were 
centrifuged at 3000 rpm for 5 min. Sera were 
collected and the levels of BUN and creatinine 
measured using a Cobas Mira Plus CC 
Chemistry Analyzer (Switzerland). 
 
Determination of MDA levels 
 
The kidney was re-suspended at 50 mg/ml in 
phosphate buffered saline (PBS) containing 1X 
butylated hydroxytoluene (BHT), homogenized 
on ice and centrifuged at 10000 x g for 5 min  to 
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collect supernatant. According to the protocol of 
OxiSelectTM TBARS Assay Kit (Cell Biolabs, Cat 
no: STA-330), 100 µl of sample or MDA standard 
was added to separate in microcentrifuge tubes; 
100 µl of the SDS lysis solution was added, 
mixed thoroughly, incubated for 5 min at room 
temperature, and 250 µl of thiobarbituric acid 
(TBA) reagent added. Each tube was closed, 
incubated at 95 °C for 60 min, removed and then 
cooled to room temperature in an ice bath for 5 
min. All the sample tubes were centrifuged at 
3000 rpm for 15 min, the supernatant removed, 
and 200 µl of which was transferred, along with 
200 µl of MDA standard, to a 96-well microplate 
compatible with a spectrophotometric plate 
reader  (Syngene, USA) and the absorbance 
read at 532 nm.  
 
Determination of SOD activity 
 
The kidney was homogenized to 50 mg/ml in 
cold 1X lysis buffer (10 mM Tris, pH 7.5, 150 mM 
NaCl, 0.1 mM EDTA), centrifuged at 12000 x g 
for 10 min and the supernatant collected for 
analysis. According to protocol of OxiSelectTM 
SOD Activity Assay Kit (Cell Biolabs, Cat No: 
STA-340), 20 µl of the sample, 5 µl of xanthine 
solution, 5 µl of chromagen solution, 5 µl of 10X 
SOD assay buffer, 50 µl of deionized water were 
mixed together to yield a total volume of 90 µl in 
a 96 well microplate; 10 µl of pre-diluted 1X 
xanthine oxidase solution was added to each 
well, mixed well, incubated for 1 h at 37 ºC and 
the absorbance read with a spectrophotometric 
plate reader at 490 nm. 
 
Determination of catalase activity 
 
The kidney was homogenized to 50 mg/ml in 
cold PBS with 1mM EDTA, centrifuged at 10000 
x g, 4 °C for 15 min and the supernatant 
collected. According to the protocol of 
OxiSelectTM Catalase Activity Assay Kit (Cell 
Biolabs, Cat No: STA-341), 20 µl of the diluted 
catalase standard or sample was added to a 96-
well microplate, 50 µl of the H2O2 working 
solution (12 mM) was added to each well, mixed 
thoroughly, incubated for 1 min, and the reaction 
stopped by adding 50 µl of catalase quencher 
into each well and mixed thoroughly; 5 µl of each 
reaction well was transferrred to a fresh well, 250 
µl of the chromogenic working solution added to 
each well, incubated for 60 min with vigorous 
mixing and its absorbance read with a 




Protein content of kidney sample was 
determined in order to calculate MDA level as 
nmol/g protein, SOD and catalase activities as 
U/mg protein by Bradford assay (Sigma, USA) 
using bovine serum albumin (BSA) as standard. 
 
Histopathological examination of kidney 
sample 
 
The kidney was preserved in 10 % neutral 
buffered formalin solution for 24 h and washed 
with 70 % ethanol. The tissue was then placed in 
small metal caskets, stirred by a magnetic stirrer, 
dehydrated using alcohol series from 70 to 100 
% and embedded in paraffin using an 
embedding machine. Paraffin block was 
sectioned using a rotary ultra microtome, 
distributed onto glass slides and then dried 
overnight. The slide was observed under a light 
microscope after being stained with hematoxylin 
and eosin (H&E) dyes and mounted. Two 
pathologists evaluated histopathological grading 
using a semi-quantitative scale: normal = 0; mild 
= < 25 %; moderate = 25 – 50 %; severe = > 50 
% of affected area. 
 
Determination of NADPH oxidase and p38-
MAPK gene expressions  
 
Total RNA was extracted from kidney tissue by 
RNeasy mini kit.  RNA content and purity were 
measured by a UV spectrophotometer. RT-PCR 
was done  using  the  extracted  RNA  for  
detection  of NADPH  oxidase  and  p38-MAPK 
genes.  For amplification of the targets genes, 
reverse transcription and PCR were run in two 
separate steps. Briefly, Reaction mixture of RT 
reaction containing 1 μg total RNA, 0.5 μg 
random primer, 5 × RT buffer, 2.5 mmol/l dNTP, 
20 U RNase inhibitor and 200 U MMLV reverse 
transcriptase in a total volume of 25 μl was 
incubated at 37 °C for 60 min, then heated to 95 
°C for 5 min to inactivate MMLV. PCR was 
carried out with 1.5 μl RT products, 10 × PCR 
buffer (without Mg2+) 2.5 μl, 2.0 μl dNTP (2.5 
mmol/l), 2.0 μl MgCl2 (25 mmol/l), 0.5 μl each 
primer (20 μmol/l) of β-actin, 0.5 μl each primer 
of gene to be tested (20 μmol/l) and 1 U of Taq 
DNA polymerase, in a final volume of 25 μl. 
Thermal cycler conditions were as follows: a first 
denaturing cycle at 97 °C for 5 min, followed by a 
variable number of cycles of amplification 
defined by denaturation at 96 °C for 1.5 min, 
annealing for 1.5 min and extension at 72 °C for 
3 min. A final extension cycle of 72 °C for 15 min 
was included [15]. The primers, including 
NADPH oxidase, p38-MAPK and β-actin, are 
illustrated in Table 1. 
 
All  PCR  products  were  electrophoresed  on  2 
%  agarose  stained with  ethidium  bromide  and  
visualized  by  UV  transilluminator. The amounts 
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of PCR products were quantified using the gel 
and image analysis software (Syngene, USA).  
 
Table 1: The primers of NADPH oxidase, p38-MAPK 
and β-actin 
 
NADPH oxidase    
Forward primer: 5’-GGAAATAGAAAGTTGACTGGCCC -3’ 
Reverse primer: 5’-GTATGAGTGCCATCCAGAGCAG-3’ 
 
p38-MAPK                
Forward primer: 5’TGACTTGCTTCCCTGTTCTTGA-3’ 
Reverse primer: 5’-TTTGGAAATGTGTCCACAGAGG-3’ 
 
β-actin                  
Forward primer: 5’TGTTGTCCCTGTATGCCTCT-3’ 





The results were expressed as mean ± standard 
deviation (SD). Differences between groups 
were determined by one-way analysis of 
variance (ANOVA). Post hoc test was performed 
for group comparisons using the least significant 





Effect of treatments on kidney function 
biomarkers 
 
Cisplatin elicited a significantly increased serum 
BUN and creatinine levels compared with saline 
group (p < 0.05) (Fig 1). Although not significant, 
curcumin and/or α-tocopherol were able to 
reduce BUN levels compared with cisplatin-
treated group (Fig 1A). Surprisingly, co-
administration of curcumin and α-tocopherol 
produced significant reduction of creatinine 
levels (p < 0.05) compared with cisplatin-treated 
group. Additionally, curcumin or α-tocopherol 
lowered creatinine levels but not significantly (Fig 
1B). 
 
Fig 1: Kidney function test of rat study groups. (A) 
Serum BUN levels. (B) Serum creatinine levels. 
Values represent mean ± SD (n = 5); *p < 0.05 
compared with cisplatin-treated group. Cis: cisplatin, 
Cur: curcumin 
 
Effect on lipid peroxidation and enzymatic 
antioxidant activities 
 
Cisplatin produced a markedly increased MDA 
levels compared with saline group (p < 0.05, Fig 
2A) which indicate enhancement of lipid 
peroxidation. Cisplatin pre-treated with curcumin 
and/or α-tocopherol-treated groups showed a 
significant reduction in MDA levels compared 
with cisplatin-treated group (p < 0.05). 
Surprisingly, cisplatin pre-treated with combined 
curcumin and α-tocopherol treated group 
demonstrated significantly reduced MDA levels 
compared with cisplatin pre-treated with α-
tocopherol or curcumin (p < 0.05). As shown in 
Fig 2B and 2C, cisplatin demonstrated marked 
reduction in SOD and calalase activities 
compared with the saline control group (p < 
0.05). Cisplatin pre-treated with curcumin and/or 
α-tocopherol treated groups showed significantly 
increased SOD and calalase activities compared 
with cisplatin-treated group (p < 0.05). 
 
Fig 2: Lipid peroxidation and enzymatic antioxidant 
activities of the rats. (A) Renal MDA levels. (B) SOD 
activity. (C) Catalase activity. Values represent the 
mean ± SD (n = 5); * p < 0.05 compared with control 
group; a,b,c p < 0.05 compared with cisplatin, cisplatin 
pre-treated with α-tocopherol and cisplatin pre-treated 
with curcumin-treated groups, respectively.  Cis: 
cisplatin, Cur: curcumin. 
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Effect of treatments on on kidney 
histopathology 
 
Cisplatin at 20 mg/kg BW caused various 
pathologies of kidney especially in tubules 
including moderate accumulation of 
proteinaceous casts in tubular lumen, tubular 
necrosis and congestion (Fig 3C and 3D). Pre-
treatment with curcumin and/or α-tocopherol 
were able to improve kidney pathology induced 




Fig 3: Effect of curcumin and/or α-tocopherol pre-
treatment on histopathological alterations upon 
cisplatin treatment in Wistar rats (H&E staining): (A, B) 
Control group. (C, D) Cisplatin-treated group. (E, F) 
Cisplatin pre-treated with α-tocopherol-treated group. 
(G, H) Cisplatin pre-treated with curcumin-treated 
group. (I, J) Cisplatin pre-treated with combined 
curcumin and α-tocopherol-treated group. Scale: 200 
and 50 µm correspond to magnification at 50 x and 
400 x, respectively. 
 
Effect of treatment on NADPH oxidase and 
p38-MAPK gene expressions   
 
As shown in Fig 4A, treatment with cisplatin 
exhibited a significant enhancement of mRNA 
levels of NADPH oxidase compared with saline 
group (p < 0.05). Cisplatin pre-treated with 
combined curcumin and α-tocopherol-treated 
groups showed significantly reduction of mRNA 
levels of NADPH oxidase compared with 
cisplatin-treated group (p < 0.05). Although the 
effects were not significant, curcumin or α-
tocopherol reduced BUN levels compared with 
cisplatin-treated group. Cisplatin exhibited the 
increased mRNA levels of p38-MAPK but did not 
significant compared with saline group (Fig 4B). 
Additionally, cisplatin pre-treated with curcumin 
and/or α-tocopherol-treated groups did not 
reduce mRNA levels of p38-MAPK compared 
with cisplatin-treated group. 
 
Table 2: Renal histological evaluation of the rats (n = 
5). 
Group* Histological 
alteration 1 2 3 4 5 
Accumulation of 
proteinaceous 
casts in tubular 
lumen 




























Severity scores: 0 = Not found; 1+ = Mild; 2+ = Moderate; 3+ 
= Severe. *1 = Control group; 2 = Cisplatin-treated group; 3 = 
Cisplatin pre-treated with α-tocopherol-treated group; 4 = 
Cisplatin pre-treated with curcumin-treated group; 5 = 
Cisplatin pre-treated with combined α-tocopherol and 
curcumin-treated group. 
 
Fig 4: NADPH oxidase and p38-MAPK gene 
expressions in the rats. (A) Agarose gel 
electrophoresis showing gene expression of NADPH 
oxidase by RT-PCR with its density compared with β-
actin. (B) Gene expressions of p38-MAPK with its 
density compared with β-actin. Values represent the 
mean ± SD (n = 5). * p < 0.05 compared with control 
group. # p < 0.05 compared with cisplatin.  Cis: 




Normally, oxidative stress was caused by 
increasing oxidants and/or reducing antioxidants. 
Oxidants include ROS and reactive nitrogen 
species (RNS) which can be produced by both 
endogenous sources (inflammatory cells, 
fibroblast, epithelial cells, endothelial cells, 
respiratory chain, xanthine and NADPH oxidase) 
and exogenous sources (cigarette smoke, 
exogenous toxins, pollution, radiation, 
carcinogens and drugs) [16]. Under normal 
physiological conditions, oxidants are scavenged 
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through antioxidant defense mechanism [17]. If 
incompletely clearance by antioxidants, oxidants 
will be caused oxidative stress. Inefficiency and 
insufficiency of antioxidant defense system are 
concerned in some pathological conditions 
induced by oxidative stress. Evidence of 
oxidative stress induced by cisplatin in kidney 
has been demonstrated in various studies [1,4].  
 
The present study demonstrated that oxidative 
stress contributes to cisplatin-induced 
nephrotoxicity by increasing MDA levels and 
reducing activities of enzymatic antioxidants 
including SOD and catalase, similarly to previous 
reports [1,15]. NADPH oxidase is a membrane-
bound enzyme complex which donates an 
electron from NADPH to molecular oxygen (O2) 
to produce O2•-. Thereafter, O2•- is converted into 
H2O2 by SOD. H2O2 is also converted to •OH by 
the Fenton reaction. We suggest that cisplatin 
play a key role in ROS production by 
enhancement of NADPH oxidase gene 
expression causing increased lipid peroxidation, 
ultimately may caused membrane damage and 
cell death. Moreover, the present study 
illustrated that oxidative stress induced by 
cisplatin caused various kidney pathologies and 
increased serum BUN and creatinine levels, 
indicating kidney dysfunction.  
 
The present study demonstrates that pre-
treatment with combined curcumin and α-
tocopherol could reduce gene expressions of 
NADPH oxidase, MDA levels, BUN and 
creatinine levels, and could increase activities of 
SOD and catalase. We suggest that curcumin 
and α-tocopherol acted as antioxidant to 
scavenge ROS, eventually abrogating oxidative 
stress and improve kidney pathology and 
function. Natural products-derived antioxidants 
are gradually high interest to investigate for 
reduce the side effects of cisplatin in various 
organs. Alpha lipoic acid plays a renoprotective 
role on cisplatin-induced nephrotoxicity through 
antioxidant and anti-apoptotic mechanisms in 
mice [1]. Chrysin or 5, 7-dihydroxyflavone which 
is present in honey and various plants revealed 
the protective effect against cisplatin-induced 
colon toxicity relating with attenuation of 
oxidative stress and apoptosis in male albino 
rats [18]. Caffeic acid phenethyl ester  which is a 
flavonoid found in the honeybee propolis extract 
elicited partial protection against cisplatin-
associated biochemical and histopathological 
alterations in the rabbit [19]. Powder of grain of 
Triticum sativum, Lisosan G, also attenuated the 
oxidative stress and the preservation in 
antioxidant enzymes induced by cisplatin in renal 
and testicular tissues of male Wistar rats [20]. 
Additionally, cisplatin revealed not significantly 
increased p38-MAPK gene expression indicating 
that occurred cell death may not be associated 
apoptotic pathway. We suggested that necrotic 




The present study has shown that oxidative 
stress plays an important role in nephrotoxicity 
induced by cisplatin. Pre-treatment with 
combined curcumin and α-tocopherol 
ameliorates cisplatin-induced nephrotoxicity via 
possible abrogation of oxidative stress. It also 
decreases gene expression of NADPH oxidase 
which is considered as one of the important 
endogenous sources of O2•-. Moreover, the 
antioxidant effect is responsible for the reduction 
of lipid peroxidation and increased activities of 
SOD and catalase, resulting in improvement of 
kidney function and histopathology. Therefore, 
pre-treatment with combined curcumin and α-
tocopherol may be useful for patients undergoing 
chemotherapy by cisplatin but further in vivo 
studies and clinical trials are required to 
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